Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c90d52528e75d4c893425c712b5eba56 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1722 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
filingDate |
2019-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ffdf1e33bfc7222abcdb9faa53dc5d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65e72d9f2681b61b22b190be5502bc68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adf558cf3cd571e5b3ef6c266247640b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b55829f5b6430e0237a4b845096f093 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97370cc95de8fa08c4d10a0c75d6b82d |
publicationDate |
2020-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10874692-B2 |
titleOfInvention |
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
abstract |
Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11660316-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11439687-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11484551-B2 |
priorityDate |
2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |